Company Analysis

Zai Lab Limited (ZLAB)

Nasdaq: ZLAB · Pharmaceutical Preparations · Shanghai · filing with the SEC since 2017
Grade6.0
◀ Past 7.1● Present 6.2▶ Future 4.6
1 est.

Who runs Zai Lab Limited

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Du Ying
Chairperson & CEO. First filing Jan 2021, latest Jul 6, 2026, 31 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
20 people on the record since 2021
Officerssales are open-market, Oct 5, 2025 to Oct 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Chen YajingChief Financial OfficerJul 2023Oct 5, 20267 · $200,000
Du YingChairperson & CEOJan 2021Jul 6, 202615 · $8.6M
Edmondson Frazor Titus IIIChief Legal OfficerJan 2021Jun 29, 20268 · $1.0M
Wang YizheOperating PartnerJun 2026Jun 8, 2026none
Amado RafaelPresident, Head of Global Oncology Research and DevelopmentDec 2022Apr 8, 20265 · $700,000
Smiley Joshua LPresident and Chief Operating OfficerAug 2022Apr 8, 20263 · $300,000
Directorssales are open-market, Oct 5, 2025 to Oct 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Lis WilliamdirectorJan 2021Aug 13, 20262 · $300,000
Gaynor RicharddirectorNov 2021Jul 6, 2026none
Diekman John DdirectorJan 2021Jun 22, 2026none
Leung NisadirectorJan 2021Jun 22, 2026none
Morrison Scott WdirectorOct 2021Jun 22, 2026none
Moulder Leon O JrdirectorJan 2021Jun 22, 2026none
Vounatsos MicheldirectorJan 2023Jun 22, 2026none
Wirth PeterdirectorJan 2021Jun 22, 2026none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ZLAB · research, not advice